Sanara MedTech (Sanara MedTech) Short Interest

View and export this data going back to 2020. Start your Free Trial

What is Sanara MedTech Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Sanara MedTech's Short Interest

For the Medical Instruments & Supplies subindustry, Sanara MedTech's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sanara MedTech's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sanara MedTech's Short Interest distribution charts can be found below:

* The bar in red indicates where Sanara MedTech's Short Interest falls into.

Sanara MedTech (Sanara MedTech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sanara MedTech Inc (NAS:SMTI) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

N/A

Address

1200 Summit Avenue, Suite 414, Fort Worth, TX, USA, 76102

Website

https://www.sanaramedtech.com

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel.

Executives

Eric D Major	director	751 MILLER DRIVE SE, LEESBURG VA 20175
Zachary B. Fleming	officer: President - Surgical Div.	1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Shawn M. Bowman	officer: President - Wound Care Div.	1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Rebecca E Mcmahon	officer: President - R&D	1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Sara N Ortwein	director	5959 LAS COLINAS BOULEVARD, IRVING TX 75039-2298
Robert Andrew Desutter	director	1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Eric D Tanzberger	director	1929 ALLEN PARKWAY, HOUSTON TX 77219
Christopher A. Morrison	officer: President - Telehealth Svcs.	1200 SUMMIT AVENUE, SUITE 414, FORT WORTH TX 76102
Roszell Iii Mack	director	1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Cgi Cellerate Rx, Llc	10 percent owner	C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
Catalyst Rochal, Llc	10 percent owner	C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
Bradley J. Gurasich	10 percent owner	C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
J Michael Carmena	director, officer: Principal Executive Officer	1200 SUMMIT AVE STE 414, FORT WORTH TX 76102
Michael D. Mcneil	officer: Chief Financial Officer	1200 SUMMIT AVE, STE 414, FORT WORTH TX 76102
Catalyst Group, Inc.	10 percent owner	1375 ENCLAVE PARKWAY, HOUSTON TX 77077